Transfer Factor for Treatment of Multiple Sclerosis

Transfer factor is not covered for treatment of multiple sclerosis because its use for that indication is considered experimental. No indications for coverage, documentation requirements, or frequency limits are specified in this policy.

"Transfer factor (dialysate of extract from sensitized leukocytes) is not covered for the treatment of multiple sclerosis because its use for this purpose is experimental."

Sign up to see full coverage criteria, indications, and limitations.